Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

Executive Summary

• Tilray Medical announced a joint‑venture with Top Tech Global Inc. to form Solana Life Group, securing a Panamanian medical cannabis license for cultivation, manufacturing, import, export, distribution and sale.
• The partnership enables Tilrow to launch and distribute its medical‑cannabis products across Panama, expanding its footprint into Latin America.
• The move is positioned as a strategic growth initiative that will broaden patient access and diversify Tilray’s international revenue streams.

Key Details

• Joint Venture Partner: Top Tech Global Inc., experienced in medical‑device distribution since 2014.
• JV Entity: Solana Life Group (Tilray Medical + Top Tech).
• License Granted: Medical cannabis license from Panama’s National Directorate of Pharmacy and Drugs authorizing full‑cycle activities – cultivation, manufacturing, import, export, distribution, and sale.
• Strategic Objectives:
• Leverage Tilray’s global expertise and Top Tech’s local market knowledge to launch medical‑cannabis products in Panama.
• Provide education, reliable supply chain, and a comprehensive cannabinoid portfolio to Panamanian healthcare professionals and patients.
• Collaborate with regulators, healthcare providers, and patient‑advocacy groups to ensure high standards and trusted therapeutic alternatives.
• Geographic Expansion: First entry into the Panama market, adding to Tilray’s presence in over 20 countries.
• Potential Impact: Expected to increase Tilray’s international sales, diversify its geographic revenue base, and strengthen its position as a global leader in medical cannabis.

Notable Quotes

(No direct quotes were provided in the release.)